Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Biopharma Has Three 2020 Shots on Goal in Pediatric Liver Diseases

The events in that trio are presented in a ROTH Capital Partners report. In a Feb. 3 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that Albireo Pharma Inc. (ALBO:NASDAQ) plans to launch three clinical trials this year in the same num...
Streetwise Reports | February 10, 2020 |

June 9th 2020, Crypto Chartbook: If it breaks we get paid

If it breaks we get paid Or not. One aspect rarely talked about is the psychological aspect on why there are so few winning traders. You might have heard about the trader who reached his goal to make a million dollars and then lost most of it. Once the strongly desired goa...
Korbinian Koller | June 10, 2020 |

Buzz on the Bullboards: 3 standout stocks in 3 standout sectors

We are already halfway through July and despite being in the midst of these sleepy summer days, both the business world and Bullboards have certainly picked up in activity. We track the most-viewed Bullboards in each sector every week and bring you some of...
Jonathon Brown | July 14, 2022 |

Ardelyx's Shares Soar 65% as Tenapanor Phase 3 Study Hits the Mark

Clinical-stage specialized biopharmaceutical company Ardelyx announced positive results today for its phase 3 AMPLIFY study for tenapanor aimed at improving treatment for cardiorenal diseases. This morning clinical-stage biopharmaceutical developer of medicines for th...
Streetwise Reports | September 4, 2019 |

T2 Biosystems Receives BARDA Contract to Fight Antimicrobial Resistance, Shares Up More than 88%

This healthcare diagnostics stock rose more than 88% on Wednesday following the award of a BARDA contract that could be worth up to $69 million. On Wednesday morning, T2 BioSystems Inc. (TTOO:NASDAQ) announced receipt of funding from the U.S. Department of Health a...
Streetwise Reports | September 12, 2019 |

Company's Share Price Takes a Hit, and This Investor Wonders Why

Aben Resources Ltd. (ABN:TSX.V; ABNAF:OTCQB) recently announced results from the first shipment of drill core from its 2019 drill program at the Forrest Kerr gold project in the Golden Triangle (GT) of British Columbia, Canada. Results from three of ten completed drill...
Streetwise Reports | August 26, 2019 |

May 18th 2020, Crypto Chartbook: Low risk precision trading

Low risk precision trading Here at Midas Touch Consulting risk control is our foremost goal . This requires endless hours of backward and forward testing of each individual market, sector, instrument and time frame to stack the odds as best as possible and extract tradin...
Korbinian Koller | May 19, 2020 |

Relmada Therapeutics Stock Soars on Phase 2 Depression Study Results

Shares of Relmada Therapeutics have traded wildly today after it announced Phase 2 results for its anti-depressant drug dextromethadone. The firm's shares have traded 100–200% higher today and the stock was halted several times trading due to extreme price volatility. ...
Streetwise Reports | October 16, 2019 |

Invitae Corp. Enters into Definitive Agreement to Acquire ArcherDX

Shares of Invitae Corp. traded 40% higher after the company reported it will acquire ArcherDX in a combination cash and stock deal valued at around $1.4 billion. Advanced medical genetics company Invitae Corp. (NVTA:NYSE) and genomics analysis firm ArcherDX today...
Streetwise Reports | June 23, 2020 |

Brazil Mine 'Demonstrates Growth is Real'

Conclusions from a recent site visit are delivered in a CIBC report. In an Oct. 4 research note, analyst Anita Soni reported that CIBC raised its valuation of Yamana Gold Inc.'s (YRI:TSX; AUY:NYSE; YAU:LSE) Jacobina mine in Brazil to $968 million from $925 million f...
Streetwise Reports | October 9, 2019 |
1 2 3 4 5 6 7 8 9 10 ...